Results 101 to 110 of about 214 (122)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management

Medicina (Lithuania), 2021
Kiran Motaparthi, Simo Huang, Motaparthi Kiran   +2 more
exaly  

A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Biomedicines, 2022
Hua-Ching Chang, Ming-Hsiu Lin, Tsung-Jen Wang   +2 more
exaly  

Stevens‐Johnson Syndrome due to COVID‐19 vaccination

Clinical Case Reports (discontinued), 2021
Nikoo Mozafari
exaly  

Daunorubicin induced Stevens‐Johnson syndrome: A case report

Clinical Case Reports (discontinued), 2021
Preeti Shakya
exaly  

The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Clinical and Applied Thrombosis/Hemostasis, 2021
Ahmed Kouta, Debra Hoppensteadt, Jodi Speiser   +2 more
exaly  

New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome

Ophthalmology, 2016
Darren G Gregory
exaly  

Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review

Journal of the American Academy of Dermatology, 2015
Ilona Frieden, Kanade Shinkai
exaly  

Allopurinol-Induced Stevens–Johnson Syndrome (SJS)

Clinical Pharmacology: Advances and Applications, 2023
exaly